Back to top

Sobi Reaffirmed at Buy as Analyst Trims Target to SEK560 Amid Long-Term Competitive Pressures

Analyst Harry Gillis from Berenberg Bank maintained a Buy rating on Swedish Orphan Biovitrum AB and decreased the price target to SEK560.00 from SE...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Swedish Orphan Biovitrum (BIOVF)